2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

[1]  Michael J Ackerman,et al.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2018, Journal of the American College of Cardiology.

[2]  S. Viskin,et al.  Long-term flecainide therapy in type 3 long QT syndrome , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  Gerasimos S Filippatos,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Journal of the American College of Cardiology.

[4]  Daniel E Forman,et al.  2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Heart rhythm.

[5]  Marmar Vaseghi,et al.  Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias. , 2017, Journal of the American College of Cardiology.

[6]  L. Fleisher,et al.  2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[7]  J. Goldberger,et al.  Sudden Cardiac Arrest Risk Assessment: Population Science and the Individual Risk Mandate , 2017, JAMA cardiology.

[8]  Amit R. Patel,et al.  Prognostic Value of Myocardial Scarring on CMR in Patients With Cardiac Sarcoidosis. , 2017, JACC. Cardiovascular imaging.

[9]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[10]  S. Szymkiewicz,et al.  Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry. , 2017, JACC. Clinical electrophysiology.

[11]  M. Link,et al.  Hypertrophic Cardiomyopathy With Left Ventricular Apical Aneurysm: Implications for Risk Stratification and Management. , 2017, Journal of the American College of Cardiology.

[12]  G. Tomaselli,et al.  Left Ventricular Dysfunction and Conduction Disturbances in Patients With Myotonic Muscular Dystrophy Type I and II , 2017, JAMA cardiology.

[13]  C. Granger,et al.  Improving Care of Out-of-Hospital Cardiac Arrest: Next Steps. , 2016, Circulation.

[14]  G. Fu,et al.  Characterization of the epicardial substrate for catheter ablation of Brugada syndrome. , 2016, Heart rhythm.

[15]  M. Ackerman,et al.  Clinical Presentation of Pediatric Patients at Risk for Sudden Cardiac Arrest. , 2016, The Journal of pediatrics.

[16]  S. Viskin,et al.  Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data , 2016, Circulation. Arrhythmia and electrophysiology.

[17]  I. Anand,et al.  Implantable Cardioverter-Defibrillator Use in Patients With Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis. , 2016, JACC. Heart failure.

[18]  Jørgen K. Kanters,et al.  Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study. , 2016, Circulation.

[19]  T. Trikalinos,et al.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine. , 2016, JAMA.

[20]  T. Sakamoto,et al.  Fontan circulation over 30 years. What should we learn from those patients? , 2016, Asian cardiovascular & thoracic annals.

[21]  T. Chao,et al.  Long-Term Outcome of Non-Sustained Ventricular Tachycardia in Structurally Normal Hearts , 2016, PloS one.

[22]  H. Huikuri,et al.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge , 2016, Journal of arrhythmia.

[23]  P. Berne,et al.  Long-Term Trends in Newly Diagnosed Brugada Syndrome: Implications for Risk Stratification. , 2016, Journal of the American College of Cardiology.

[24]  A. Raissadati,et al.  Late Causes of Death After Pediatric Cardiac Surgery: A 60-Year Population-Based Study. , 2016, Journal of the American College of Cardiology.

[25]  P. Leprince,et al.  Implantable cardioverter-defibrillators in end-stage heart failure patients listed for heart transplantation: Results from a large retrospective registry. , 2016, Archives of cardiovascular diseases.

[26]  M. Poetsch,et al.  The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths , 2016, International Journal of Legal Medicine.

[27]  J. Cho,et al.  Prognosis of Variant Angina Manifesting as Aborted Sudden Cardiac Death. , 2016, Journal of the American College of Cardiology.

[28]  D. Packer,et al.  Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease. , 2016, Heart rhythm.

[29]  J. Goldberger,et al.  Lifetime Risk for Sudden Cardiac Death in the Community , 2016, Journal of the American Heart Association.

[30]  R. Peinado,et al.  Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study , 2016, European heart journal.

[31]  J. Skinner,et al.  A Prospective Study of Sudden Cardiac Death among Children and Young Adults. , 2016, The New England journal of medicine.

[32]  H. Shimokawa,et al.  Time Course and Factors Correlating With Ventricular Tachyarrhythmias After Introduction of Steroid Therapy in Cardiac Sarcoidosis , 2016, Circulation. Arrhythmia and electrophysiology.

[33]  Matthew S. Yong,et al.  Outcomes of Truncus Arteriosus Repair in Children: 35 Years of Experience From a Single Institution. , 2016, Seminars in thoracic and cardiovascular surgery.

[34]  H. Huikuri,et al.  Temporal Trends in the Clinical and Pathological Characteristics of Victims of Sudden Cardiac Death in the Absence of Previously Identified Heart Disease , 2016, Circulation. Arrhythmia and electrophysiology.

[35]  D. Tester,et al.  Whole-Exome Molecular Autopsy After Exertion-Related Sudden Unexplained Death in the Young , 2016, Circulation. Cardiovascular genetics.

[36]  I. V. Van Gelder,et al.  Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen? , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[37]  O. Dekkers,et al.  Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot , 2016, European heart journal.

[38]  L. Hudsmith,et al.  Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[39]  L. Eckardt,et al.  Long-time “real-life” performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation , 2016, Journal of Interventional Cardiac Electrophysiology.

[40]  O. Tutarel,et al.  Cause of death in adults with congenital heart disease - An analysis of the German National Register for Congenital Heart Defects. , 2016, International journal of cardiology.

[41]  B. Mulder,et al.  Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. , 2016, European heart journal.

[42]  John L Sapp,et al.  Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. , 2016, The New England journal of medicine.

[43]  M. Link,et al.  Clinical Presentation and Outcomes by Sex in Arrhythmogenic Right Ventricular Cardiomyopathy: Findings from the North American ARVC Registry , 2016, Journal of cardiovascular electrophysiology.

[44]  J. Siebermair,et al.  Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[45]  C. Canniffe,et al.  Implantable cardioverter-defibrillators in a heart transplant population: A single-center experience. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[46]  P. Kudenchuk,et al.  Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association , 2016, Circulation.

[47]  R. Furlan,et al.  Implantable loop recorder versus conventional diagnostic workup for unexplained recurrent syncope. , 2016, The Cochrane database of systematic reviews.

[48]  Raymond L Woosley,et al.  Predicting the Unpredictable: Drug-Induced QT Prolongation and Torsades de Pointes. , 2016, Journal of the American College of Cardiology.

[49]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Circulation.

[50]  C. Callaway,et al.  Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. , 2016, The New England journal of medicine.

[51]  J. Rouleau,et al.  Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy. , 2016, The New England journal of medicine.

[52]  Ken Nagao,et al.  Strategies to improve cardiac arrest survival: a time to act , 2016, Acute medicine & surgery.

[53]  D. Andreini,et al.  COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY VERSUS STRESS CARDIAC MAGNETIC RESONANCE FOR THE MANAGEMENT OF SYMPTOMATIC REVASCULARIZED PATIENTS: A COST EFFECTIVENESS STUDY (STRATEGY STUDY) , 2016 .

[54]  S. Priori,et al.  Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3 , 2016, Journal of the American College of Cardiology.

[55]  R. Hauer,et al.  Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2016, European heart journal.

[56]  A. Auricchio,et al.  True idiopathic ventricular fibrillation in out‐of‐hospital cardiac arrest survivors in the Swiss Canton Ticino: prevalence, clinical features, and long‐term follow‐up , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[57]  F. Marchlinski,et al.  Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial. , 2016, Journal of the American College of Cardiology.

[58]  Jagmeet P. Singh,et al.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[59]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[60]  Mark D. Huffman,et al.  Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association , 2016, Circulation.

[61]  H. Mallidi,et al.  Safety and Feasibility of Open Chest Epicardial Mapping and Ablation of Ventricular Tachycardia During the Period of Left Ventricular Assist Device Implantation , 2016, Journal of cardiovascular electrophysiology.

[62]  Amit R. Patel,et al.  Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction , 2016, Circulation. Cardiovascular imaging.

[63]  S. Brunak,et al.  Familial Atrial Septal Defect and Sudden Cardiac Death: Identification of a Novel NKX2‐5 Mutation and a Review of the Literature , 2015, Congenital heart disease.

[64]  G. Rada,et al.  Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death. , 2015, The Cochrane database of systematic reviews.

[65]  K. Cao,et al.  Catheter Ablation of Fascicular Ventricular Tachycardia , 2015, Circulation. Arrhythmia and electrophysiology.

[66]  D. Lin,et al.  Long-Term Outcome With Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy , 2015, Circulation. Arrhythmia and electrophysiology.

[67]  S. Viskin,et al.  Management of Brugada Syndrome: Thirty-Three–Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs , 2015, Circulation. Arrhythmia and electrophysiology.

[68]  J. Brugada,et al.  Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation , 2015, Circulation. Arrhythmia and electrophysiology.

[69]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators: A Scientific Statement From the American Heart Association and Amer , 2015, Journal of the American College of Cardiology.

[70]  C. Semsarian,et al.  Molecular autopsy in victims of inherited arrhythmias , 2015, Journal of arrhythmia.

[71]  P. Ellinor,et al.  Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis , 2016, Circulation.

[72]  C. Callaway,et al.  Cardiac Arrest in Pregnancy: A Scientific Statement From the American Heart Association , 2015, Circulation.

[73]  Roger D. White,et al.  Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2015, Circulation.

[74]  W. Shen,et al.  Advances in the pharmacologic treatment of ventricular arrhythmias , 2015, Expert opinion on pharmacotherapy.

[75]  E. Kaufman,et al.  Long‐QT Syndrome and Therapy for Attention Deficit/Hyperactivity Disorder , 2015, Journal of cardiovascular electrophysiology.

[76]  P. Brugada,et al.  Asymptomatic Brugada Syndrome: Clinical Characterization and Long-Term Prognosis , 2015, Circulation. Arrhythmia and electrophysiology.

[77]  S. Szymkiewicz,et al.  Wearable cardioverter-defibrillator as a bridge to cardiac transplantation: A national database analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[78]  Sameer Parpia,et al.  The prevalence and significance of a short QT interval in 18 825 low-risk individuals including athletes , 2015, British Journal of Sports Medicine.

[79]  K. Dimopoulos,et al.  Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre , 2015, Circulation.

[80]  Dhanunjaya R. Lakkireddy,et al.  Freedom from recurrent ventricular tachycardia after catheter ablation is associated with improved survival in patients with structural heart disease: An International VT Ablation Center Collaborative Group study. , 2015, Heart rhythm.

[81]  A. Zwinderman,et al.  Secundum atrial septal defect is associated with reduced survival in adult men , 2015 .

[82]  M. Link,et al.  Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2015, Circulation.

[83]  P. Brugada,et al.  Prognostic Value of Programmed Electrical Stimulation in Brugada Syndrome: 20 Years Experience , 2015, Circulation. Arrhythmia and electrophysiology.

[84]  D. Delurgio,et al.  Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End‐Stage Renal Disease on Dialysis , 2015, Journal of cardiovascular electrophysiology.

[85]  M. Link,et al.  Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement , 2015, European heart journal.

[86]  M. Link,et al.  Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. , 2015, European heart journal.

[87]  R. Kobza,et al.  Utility of electrophysiological studies to predict arrhythmic events. , 2015, World journal of cardiology.

[88]  L. Cooper,et al.  Long-term risk of recurrence, morbidity and mortality in giant cell myocarditis. , 2015, The American journal of cardiology.

[89]  W. Stevenson,et al.  Surgical cryoablation for ventricular tachyarrhythmia arising from the left ventricular outflow tract region. , 2015, Heart rhythm.

[90]  Jeffrey M. Vinocur,et al.  Catecholaminergic Polymorphic Ventricular Tachycardia in Children: Analysis of Therapeutic Strategies and Outcomes From an International Multicenter Registry , 2015, Circulation. Arrhythmia and electrophysiology.

[91]  W. Stevenson,et al.  Role of Alternative Interventional Procedures When Endo- and Epicardial Catheter Ablation Attempts for Ventricular Arrhythmias Fail , 2015, Circulation. Arrhythmia and electrophysiology.

[92]  Stefan L. Zimmerman,et al.  Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members , 2015, Circulation. Cardiovascular genetics.

[93]  W. Groh,et al.  Arrhythmias in the muscular dystrophies. , 2015, Cardiac electrophysiology clinics.

[94]  J. Lusson,et al.  A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field , 2015, European Journal of Human Genetics.

[95]  Pier D. Lambiase,et al.  Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS Registry. , 2015, Journal of the American College of Cardiology.

[96]  H. Calkins,et al.  Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2015, Heart rhythm.

[97]  Takumi Yamada,et al.  Radiofrequency Catheter Ablation of Idiopathic Ventricular Arrhythmias Originating From Intramural Foci in the Left Ventricular Outflow Tract: Efficacy of Sequential Versus Simultaneous Unipolar Catheter Ablation , 2015, Circulation. Arrhythmia and electrophysiology.

[98]  J. Seidman,et al.  NKX2-5 Mutations in an Inbred Consanguineous Population: Genetic and Phenotypic Diversity , 2015, Scientific Reports.

[99]  San-Kuei Huang,et al.  Arrhythmic burdens in patients with tetralogy of Fallot: a national database study. , 2015, Heart rhythm.

[100]  J. Airaksinen,et al.  Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. , 2015, Circulation.

[101]  Hiroshi Ito,et al.  Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis. , 2015, The American journal of cardiology.

[102]  H. Schaff,et al.  Ventricular Arrhythmia Risk Stratification in Patients With Tetralogy of Fallot at the Time of Pulmonary Valve Replacement , 2015, Circulation. Arrhythmia and electrophysiology.

[103]  Paul L. Hess,et al.  Catheter Ablation for Ventricular Tachycardia in Patients with an Implantable Cardioverter Defibrillator (CALYPSO) Pilot Trial , 2015, Journal of cardiovascular electrophysiology.

[104]  V. Russo,et al.  ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[105]  W. Stevenson,et al.  Re-Entry Using Anatomically Determined Isthmuses: A Curable Ventricular Tachycardia in Repaired Congenital Heart Disease , 2015, Circulation. Arrhythmia and electrophysiology.

[106]  Yu-Feng Hu,et al.  Long-term outcome of multiform premature ventricular complexes in structurally normal heart. , 2015, International journal of cardiology.

[107]  J. Kautzner,et al.  Role of electrophysiological studies in predicting risk of ventricular arrhythmia in early repolarization syndrome. , 2015, Journal of the American College of Cardiology.

[108]  L. Wilkins,et al.  Incidence and Risk Factors of Ventricular Fibrillation Before Primary Angioplasty in Patients With First ST‐Elevation Myocardial Infarction: A Nationwide Study in Denmark , 2015, Journal of the American Heart Association.

[109]  A. Jaffe,et al.  2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[110]  S. Russell,et al.  Exercise has a Disproportionate Role in the Pathogenesis of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in Patients Without Desmosomal Mutations , 2014, Journal of the American Heart Association.

[111]  Shawn D. Feinstein,et al.  Magnetic Resonance Imaging for Identifying Patients With Cardiac Sarcoidosis and Preserved or Mildly Reduced Left Ventricular Function at Risk of Ventricular Arrhythmias , 2014, Circulation. Arrhythmia and electrophysiology.

[112]  L. Morrison,et al.  Trends in Short- and Long-Term Survival Among Out-of-Hospital Cardiac Arrest Patients Alive at Hospital Arrival , 2014, Circulation.

[113]  G. Barón-Esquivias,et al.  Prognostic value of the electrocardiogram in patients with syncope: data from the group for syncope study in the emergency room (GESINUR). , 2014, Heart rhythm.

[114]  W. Book,et al.  Lesion‐Specific Differences for Implantable Cardioverter Defibrillator Therapies in Adults with Congenital Heart Disease , 2014, Pacing and clinical electrophysiology : PACE.

[115]  Donna K Arnett,et al.  AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services. , 2014, Journal of the American College of Cardiology.

[116]  T. Edvardsen,et al.  Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members , 2014, European journal of heart failure.

[117]  S. Kaufman,et al.  “It's Not Broke, So Let's Not Try to Fix It”: Why Patients Decline a Cardiovascular Implantable Electronic Device , 2014, Pacing and clinical electrophysiology : PACE.

[118]  P. Kirchhof,et al.  EHRA / HRS / APHRS expert consensus on ventricular arrhythmias , 2014 .

[119]  Jeffrey L. Anderson,et al.  The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[120]  A. Moss,et al.  Efficacy of different beta-blockers in the treatment of long QT syndrome. , 2014, Journal of the American College of Cardiology.

[121]  M. Chung,et al.  HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. , 2014, Journal of the American College of Cardiology.

[122]  J. Kovach,et al.  Arrhythmias and sudden death among older children and young adults following tetralogy of Fallot repair in the current era: are previously reported risk factors still applicable? , 2014, Congenital heart disease.

[123]  N. Buckley,et al.  Digoxin-specific antibody fragments in the treatment of digoxin toxicity , 2014, Clinical toxicology.

[124]  W. Stevenson,et al.  Left-Sided Ablation of Ventricular Tachycardia in Adults With Repaired Tetralogy of Fallot: A Case Series , 2014, Circulation. Arrhythmia and electrophysiology.

[125]  Giuseppe Limongelli,et al.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). , 2014, European heart journal.

[126]  P. Brugada,et al.  Comparison of the patient-activated event recording system vs. traditional 24 h Holter electrocardiography in individuals with paroxysmal palpitations or dizziness. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[127]  M. Link,et al.  Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment. , 2014, Journal of the American College of Cardiology.

[128]  Ashley M. Lee,et al.  Effect of the 2010 task force criteria on reclassification of cardiovascular magnetic resonance criteria for arrhythmogenic right ventricular cardiomyopathy , 2014, Journal of Cardiovascular Magnetic Resonance.

[129]  Amit R. Patel,et al.  HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. , 2014, Heart rhythm.

[130]  M. Link,et al.  B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias. , 2014, Heart rhythm.

[131]  Diane Lacaille,et al.  2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk , 2014 .

[132]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[133]  W. Kraus,et al.  Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure. , 2014, JACC. Heart failure.

[134]  J. Healey,et al.  Procainamide infusion in the evaluation of unexplained cardiac arrest: from the Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). , 2014, Heart rhythm.

[135]  A. Sato,et al.  Systematic Treatment Approach to Ventricular Tachycardia in Cardiac Sarcoidosis , 2014, Circulation. Arrhythmia and electrophysiology.

[136]  E. Behr,et al.  The importance of specialist cardiac histopathological examination in the investigation of young sudden cardiac deaths. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[137]  B. Gersh,et al.  Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. , 2014, Mayo Clinic proceedings.

[138]  C. Callaway,et al.  Time to administration of epinephrine and outcome after in-hospital cardiac arrest with non-shockable rhythms: retrospective analysis of large in-hospital data registry , 2014, BMJ : British Medical Journal.

[139]  B. Maron,et al.  Hypertrophic cardiomyopathy: one gene … but many phenotypes. , 2014, The American journal of cardiology.

[140]  M. Chung.  The role of the wearable cardioverter defibrillator in clinical practice. , 2014, Cardiology clinics.

[141]  S. Priori,et al.  Novel Insight Into the Natural History of Short QT Syndrome , 2014, Journal of the American College of Cardiology.

[142]  Johan Duflou,et al.  Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young. , 2014, Heart rhythm.

[143]  Yingying Tang,et al.  Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. , 2014, Forensic science international.

[144]  P. Lambiase,et al.  Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry , 2014, European heart journal.

[145]  D. Stacey,et al.  Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients’ Perspectives , 2014, The Patient - Patient-Centered Outcomes Research.

[146]  K. Dimopoulos,et al.  Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. , 2014, European heart journal.

[147]  C. Kramer,et al.  Late Gadolinium Enhancement on Cardiac Magnetic Resonance Predicts Adverse Cardiovascular Outcomes in Nonischemic Cardiomyopathy: A Systematic Review and Meta-Analysis , 2014, Circulation. Cardiovascular imaging.

[148]  A. Mahajan,et al.  Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. , 2014, Heart rhythm.

[149]  G. Hindricks,et al.  Outcomes in Catheter Ablation of Ventricular Tachycardia in Dilated Nonischemic Cardiomyopathy Compared With Ischemic Cardiomyopathy: Results From the Prospective Heart Centre of Leipzig VT (HELP-VT) Study , 2014, Circulation.

[150]  V. Zipunnikov,et al.  Radiofrequency Ablation Versus Antiarrhythmic Medication for Treatment of Ventricular Premature Beats From the Right Ventricular Outflow Tract: Prospective Randomized Study , 2014, Circulation. Arrhythmia and electrophysiology.

[151]  A. Moss,et al.  Syncope in High-Risk Cardiomyopathy Patients With Implantable Defibrillators: Frequency, Risk Factors, Mechanisms, and Association With Mortality Results From the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT) Study , 2014, Circulation.

[152]  T. Dickfeld,et al.  Cardiac Sarcoidosis: Electrophysiological Outcomes on Long‐Term Follow‐Up and the Role of the Implantable Cardioverter‐Defibrillator , 2014, Journal of cardiovascular electrophysiology.

[153]  Joseph P Ornato,et al.  Pulseless electric activity: definition, causes, mechanisms, management, and research priorities for the next decade: report from a National Heart, Lung, and Blood Institute workshop. , 2013, Circulation.

[154]  D. Corrado,et al.  Compound and Digenic Heterozygosity Predicts Lifetime Arrhythmic Outcome and Sudden Cardiac Death in Desmosomal Gene–Related Arrhythmogenic Right Ventricular Cardiomyopathy , 2013, Circulation. Cardiovascular genetics.

[155]  Young-Hoon Kim,et al.  Electrophysiological Characteristics Related to Outcome after Catheter Ablation of Idiopathic Ventricular Arrhythmia Originating from the Papillary Muscle in the Left Ventricle , 2013, Korean circulation journal.

[156]  E. Cantero-Pérez,et al.  Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation. , 2013, Transplantation proceedings.

[157]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[158]  V. Menon,et al.  Faculty Opinions recommendation of 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013 .

[159]  Stefan L. Zimmerman,et al.  Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[160]  M. Olesen,et al.  High prevalence of genetic variants previously associated with Brugada syndrome in new exome data , 2013, Clinical genetics.

[161]  P. Kudenchuk,et al.  Prophylactic lidocaine for post resuscitation care of patients with out-of-hospital ventricular fibrillation cardiac arrest. , 2013, Resuscitation.

[162]  J. Kalman,et al.  Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes. , 2013, Heart rhythm.

[163]  K. Gauvreau,et al.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort , 2013, Heart.

[164]  S. Kaptoge,et al.  Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations. , 2013, The American journal of cardiology.

[165]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[166]  E. Behr,et al.  Genetic testing for inherited cardiac disease , 2013, Nature Reviews Cardiology.

[167]  F. Anselme,et al.  Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders. , 2013, Heart rhythm.

[168]  Wataru Shimizu,et al.  HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes , 2013 .

[169]  S. Russell,et al.  Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. , 2013, Journal of the American College of Cardiology.

[170]  Jeffrey L. Anderson,et al.  2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[171]  Katja Zeppenfeld,et al.  Contrast-Enhanced MRI–Derived Scar Patterns and Associated Ventricular Tachycardias in Nonischemic Cardiomyopathy: Implications for the Ablation Strategy , 2013, Circulation. Arrhythmia and electrophysiology.

[172]  A. Wilde,et al.  Mutation Location Effect on Severity of Phenotype During Exercise Testing in Type 1 Long‐QT Syndrome: Impact of Transmembrane and C‐Loop Location , 2013, Journal of cardiovascular electrophysiology.

[173]  M. O. Al Chekakie,et al.  Traditional heart failure medications and sudden cardiac death prevention: a review. , 2013, Journal of cardiovascular pharmacology and therapeutics.

[174]  Mark Kremers,et al.  Safety and Efficacy of a Totally Subcutaneous Implantable-Cardioverter Defibrillator , 2013, Circulation.

[175]  M. Turakhia,et al.  Diagnostic utility of a novel leadless arrhythmia monitoring device. , 2013, The American journal of cardiology.

[176]  P. Kirchhof,et al.  Tachycardia detection performance of implantable loop recorders: results from a large 'real-life' patient cohort and patients with induced ventricular arrhythmias. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[177]  J. Roos‐Hesselink,et al.  The unnatural history of an atrial septal defect: Longitudinal 35 year follow up after surgical closure at young age , 2013, Heart.

[178]  R. Swor,et al.  Rapid epinephrine administration improves early outcomes in out-of-hospital cardiac arrest. , 2013, Resuscitation.

[179]  Y. Yokoyama,et al.  Prognosis and risk stratification of young adults with Brugada syndrome. , 2013, Journal of electrocardiology.

[180]  R. Hetzer,et al.  Prophylactic implantable cardioverter defibrillator treatment in patients with end-stage heart failure awaiting heart transplantation , 2013, Heart.

[181]  H. Putter,et al.  Suitability for subcutaneous defibrillator implantation: results based on data from routine clinical practice , 2013, Heart.

[182]  Perry M Elliott,et al.  A systematic review and meta-analysis of genotype–phenotype associations in patients with hypertrophic cardiomyopathy caused by sarcomeric protein mutations , 2013, Heart.

[183]  J. Towbin,et al.  Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. , 2013, Journal of the American College of Cardiology.

[184]  C. Bhamidipati,et al.  Cryoablation during left ventricular assist device implantation reduces postoperative ventricular tachyarrhythmias. , 2013, The Journal of thoracic and cardiovascular surgery.

[185]  J. Atherton,et al.  Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy , 2013, Genetics in Medicine.

[186]  J. Chibnall,et al.  Patient perceptions, physician communication, and the implantable cardioverter-defibrillator. , 2013, JAMA internal medicine.

[187]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[188]  Wataru Shimizu,et al.  Long-term follow-up of a pediatric cohort with short QT syndrome. , 2013, Journal of the American College of Cardiology.

[189]  Jagmeet P. Singh,et al.  Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[190]  Kai H. Lee,et al.  Cardiovascular imaging of the pregnant patient. , 2013, AJR. American journal of roentgenology.

[191]  Jane A. Linderbaum,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[192]  L. Held,et al.  Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy. , 2013, The American journal of cardiology.

[193]  Deepak L. Bhatt,et al.  ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[194]  Tim Smith,et al.  The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis. , 2013, European heart journal.

[195]  K. Salmenkivi,et al.  Diagnosis, Treatment, and Outcome of Giant-Cell Myocarditis in the Era of Combined Immunosuppression , 2013, Circulation. Heart failure.

[196]  L. Køber,et al.  Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents: A 12-Year Follow-up Study of Clinical Screening and Predictive Genetic Testing , 2013, Circulation.

[197]  G. Trillò,et al.  Impact of emergency coronary angiography on in-hospital outcome of unconscious survivors after out-of-hospital cardiac arrest. , 2012, The American journal of cardiology.

[198]  S. Szymkiewicz,et al.  Wearable defibrillator use in heart failure (WIF): results of a prospective registry , 2012, BMC Cardiovascular Disorders.

[199]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, The Journal of thoracic and cardiovascular surgery.

[200]  苅尾 七臣,et al.  ガイドライン解説 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease : 2011 update , 2012 .

[201]  R. Hauer,et al.  Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. , 2015, European heart journal.

[202]  S. Russell,et al.  Risk Stratification in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy–Associated Desmosomal Mutation Carriers , 2012, Circulation. Arrhythmia and electrophysiology.

[203]  L. Jordaens,et al.  The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort. , 2012, Journal of the American College of Cardiology.

[204]  W. Groh.  Arrhythmias in the muscular dystrophies. , 2012, Heart rhythm.

[205]  P. Schwartz,et al.  Spectrum and Prevalence of Mutations Involving Brs1-through Brs12-susceptibility Genes in a Cohort of Unrelated Patients Referred for Brugada Syndrome Genetic Testing Implications for Genetic Testing , 2022 .

[206]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Journal of the American College of Cardiology.

[207]  K. Mattocks,et al.  Patients’ Attitudes and Perceptions of Implantable Cardioverter‐Defibrillators: Potential Barriers to Appropriate Primary Prophylaxis , 2012, Pacing and clinical electrophysiology : PACE.

[208]  A. Peters,et al.  A meta-analysis of genome-wide association studies of the electrocardiographic early repolarization pattern. , 2012, Heart rhythm.

[209]  B. Sunsaneewitayakul,et al.  Endocardial Mapping and Catheter Ablation for Ventricular Fibrillation Prevention in Brugada Syndrome , 2012, Journal of cardiovascular electrophysiology.

[210]  J. Deharo,et al.  Electrical Storm in Short‐QT Syndrome Successfully Treated with Isoproterenol , 2012, Journal of cardiovascular electrophysiology.

[211]  Thomas C. Crawford,et al.  Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis , 2012, Journal of cardiovascular electrophysiology.

[212]  M. Steinmetz,et al.  Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome , 2012, Clinical Research in Cardiology.

[213]  J. López-Sendón,et al.  Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. , 2012, The American journal of cardiology.

[214]  F. Pluchinotta,et al.  Coronary Arteries in Childhood Heart Disease: Implications for Management of Young Adults. , 2012, Journal of clinical & experimental cardiology.

[215]  S. Russell,et al.  Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.

[216]  A. Wilde,et al.  The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. , 2012, Heart rhythm.

[217]  D. Tester,et al.  Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. , 2012, Mayo Clinic proceedings.

[218]  E. Kaufman,et al.  Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome. , 2012, Heart rhythm.

[219]  K. Dimopoulos,et al.  Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of Fallot , 2012, Circulation.

[220]  C. Kramer,et al.  Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.

[221]  A. Wilde,et al.  Mortality of Inherited Arrhythmia Syndromes: Insight Into Their Natural History , 2012, Circulation. Cardiovascular genetics.

[222]  A. Hagihara,et al.  Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. , 2012, JAMA.

[223]  Jon Hainer,et al.  Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. , 2012, Journal of the American College of Cardiology.

[224]  M Juhani Junttila,et al.  Sudden Cardiac Death Caused by Coronary Heart Disease , 2012, Circulation.

[225]  J. Brugada,et al.  Combined Endocardial and Epicardial Catheter Ablation in Arrhythmogenic Right Ventricular Dysplasia Incorporating Scar Dechanneling Technique , 2012, Circulation. Arrhythmia and electrophysiology.

[226]  I. V. Van Gelder,et al.  Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease: Who Is at Risk of Shocks? , 2012, Circulation. Arrhythmia and electrophysiology.

[227]  Kyle W. Klarich,et al.  Premature Ventricular Contraction-Induced Cardiomyopathy: A Treatable Condition , 2012, Circulation. Arrhythmia and electrophysiology.

[228]  G. Eide,et al.  Predictors of Heart-Focused Anxiety in Patients Undergoing Genetic Investigation and Counseling of Long QT Syndrome or Hypertrophic Cardiomyopathy: A One Year Follow-up , 2012, Journal of Genetic Counseling.

[229]  A. Zwinderman,et al.  Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. , 2012, Journal of the American College of Cardiology.

[230]  D. Grobbee,et al.  Circumstances of death in adult congenital heart disease. , 2012, International journal of cardiology.

[231]  S. Priori,et al.  [Risk stratification in Brugada syndrome]. , 2011, Giornale italiano di cardiologia.

[232]  V. Froelicher,et al.  Natural history of the electrocardiographic pattern of early repolarization in ambulatory patients. , 2011, The American journal of cardiology.

[233]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[234]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Soci , 2011, Journal of the American College of Cardiology.

[235]  Janet S. Wright,et al.  2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi , 2011, Journal of the American College of Cardiology.

[236]  J. Ganley,et al.  Genotype- and Mutation Site–Specific QT Adaptation During Exercise, Recovery, and Postural Changes in Children With Long-QT Syndrome , 2011, Circulation. Arrhythmia and electrophysiology.

[237]  Changyu Shen,et al.  Pacemaker and Implantable Cardioverter‐Defibrillator Use in a US Myotonic Dystrophy Type 1 Population , 2011, Journal of cardiovascular electrophysiology.

[238]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[239]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[240]  Nandita Mitra,et al.  Incidence of treated cardiac arrest in hospitalized patients in the United States* , 2011, Critical care medicine.

[241]  L. Fauchier,et al.  The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications , 2011, Heart.

[242]  D. Tester,et al.  Unexplained drownings and the cardiac channelopathies: a molecular autopsy series. , 2011, Mayo Clinic proceedings.

[243]  H. Huikuri,et al.  Causes of nonischemic sudden cardiac death in the current era. , 2011, Heart rhythm.

[244]  Michael J Ackerman,et al.  Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome. , 2011, Heart rhythm.

[245]  S. Russell,et al.  Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. , 2011, Journal of the American College of Cardiology.

[246]  J. Finn,et al.  Effect of adrenaline on survival in out-of-hospital cardiac arrest: A randomised double-blind placebo-controlled trial. , 2011, Resuscitation.

[247]  Andrea Mazzanti,et al.  Long-term follow-up of patients with short QT syndrome. , 2011, Journal of the American College of Cardiology.

[248]  M. Acker,et al.  Surgical Ablation of Refractory Ventricular Tachycardia in Patients With Nonischemic Cardiomyopathy , 2011, Circulation. Arrhythmia and electrophysiology.

[249]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[250]  A. Verma,et al.  Ablation of Ventricular Arrhythmias in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Arrhythmia-Free Survival After Endo-Epicardial Substrate Based Mapping and Ablation , 2011, Circulation. Arrhythmia and electrophysiology.

[251]  P. Lambiase,et al.  The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy , 2011, Heart.

[252]  L. Fauchier,et al.  Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices. , 2011, International journal of cardiology.

[253]  P. Elliott,et al.  Familial Evaluation in Arrhythmogenic Right Ventricular Cardiomyopathy: Impact of Genetics and Revised Task Force Criteria , 2011, Circulation.

[254]  B. Yashiro,et al.  Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy. , 2011, Journal of the American College of Cardiology.

[255]  R. Hauer,et al.  Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.

[256]  H. Shimokawa,et al.  Clinical Characteristics and Long-Term Prognosis of Vasospastic Angina Patients Who Survived Out-of-Hospital Cardiac Arrest: Multicenter Registry Study of the Japanese Coronary Spasm Association , 2011, Circulation. Arrhythmia and electrophysiology.

[257]  Wojciech Zareba,et al.  Risk Stratification for Arrhythmic Sudden Cardiac Death: Identifying the Roadblocks , 2011, Circulation.

[258]  A. Wilde,et al.  Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. , 2011, Journal of the American College of Cardiology.

[259]  C. Lory,et al.  Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fibrillation , 2011, Critical care.

[260]  P. Ho,et al.  Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®). , 2011, American heart journal.

[261]  H. Calkins,et al.  Meta-analysis of catheter ablation as an adjunct to medical therapy for treatment of ventricular tachycardia in patients with structural heart disease. , 2011, Heart rhythm.

[262]  K. Yodogawa,et al.  Effect of Corticosteroid Therapy on Ventricular Arrhythmias in Patients with Cardiac Sarcoidosis , 2011, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[263]  Tachapong Ngarmukos,et al.  Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium , 2011, Circulation.

[264]  M. Friedrich,et al.  Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. , 2011, JACC. Cardiovascular imaging.

[265]  M. Gollob,et al.  The short QT syndrome: proposed diagnostic criteria. , 2011, Journal of the American College of Cardiology.

[266]  Kevin L. Thomas,et al.  Systematic review of the incidence of sudden cardiac death in the United States. , 2011, Journal of the American College of Cardiology.

[267]  D. Bluemke,et al.  Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2011, Heart rhythm.

[268]  B. Caffo,et al.  Clinical Predictors of Conduction Disease Progression in Type I Myotonic Muscular Dystrophy , 2011, Pacing and clinical electrophysiology : PACE.

[269]  Michael J. Ackerman,et al.  Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals. , 2011, Journal of the American College of Cardiology.

[270]  Changyu Shen,et al.  Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1. , 2010, American heart journal.

[271]  E. Kaufman,et al.  Trigger-specific risk factors and response to therapy in long QT syndrome type 2. , 2010, Heart rhythm.

[272]  Mark E. Anderson,et al.  Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop , 2010, Circulation.

[273]  J. Healey,et al.  Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands , 2011, Circulation.

[274]  B. Gersh,et al.  Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.

[275]  M. Shuster,et al.  Part 12: cardiac arrest in special situations: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. , 2010, Circulation.

[276]  B. Desjardins,et al.  Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles. , 2010, Heart rhythm.

[277]  Ana Morales,et al.  Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals , 2010, Genetics in Medicine.

[278]  F. Gaita,et al.  Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach , 2010, European heart journal.

[279]  J. Hartikainen,et al.  Long-Term Recording of Cardiac Arrhythmias With an Implantable Cardiac Monitor in Patients With Reduced Ejection Fraction After Acute Myocardial Infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) Study , 2010, Circulation.

[280]  M. Link,et al.  Prophylactic Implantable Defibrillator in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and No Prior Ventricular Fibrillation or Sustained Ventricular Tachycardia , 2010, Circulation.

[281]  Joseph D. Kay,et al.  Arrhythmia Burden in Adults With Surgically Repaired Tetralogy of Fallot: A Multi-Institutional Study , 2010, Circulation.

[282]  A. Moss,et al.  Beta‐Blocker Efficacy in High‐Risk Patients with the Congenital Long‐QT Syndrome Types 1 and 2: Implications for Patient Management , 2010, Journal of cardiovascular electrophysiology.

[283]  I. Kowalik,et al.  Implantable Cardioverter‐Defibrillator in Patients With Hypertrophic Cardiomyopathy: Efficacy and Complications of the Therapy in Long‐Term Follow‐up , 2010, Journal of cardiovascular electrophysiology.

[284]  M. Chung,et al.  Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. , 2010, Journal of the American College of Cardiology.

[285]  A. Skanes,et al.  Utility of the recovery electrocardiogram after exercise: a novel indicator for the diagnosis and genotyping of long QT syndrome? , 2010, Heart rhythm.

[286]  Alexander H Maass,et al.  An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.

[287]  F. Morady,et al.  Ventricular arrhythmias originating from papillary muscles in the right ventricle. , 2010, Heart rhythm.

[288]  P. Kudenchuk,et al.  Procainamide and survival in ventricular fibrillation out-of-hospital cardiac arrest. , 2010, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[289]  X. Jouven,et al.  Immediate Percutaneous Coronary Intervention Is Associated With Better Survival After Out-of-Hospital Cardiac Arrest: Insights From the PROCAT (Parisian Region Out of Hospital Cardiac Arrest) Registry , 2010, Circulation. Cardiovascular interventions.

[290]  A. Wilde,et al.  The Response of the QT Interval to the Brief Tachycardia Provoked by Standing: A Bedside Test for Diagnosing Long QT Syndrome , 2010 .

[291]  D. Grobbee,et al.  Mortality in adult congenital heart disease. , 2010, European heart journal.

[292]  Michael J Ackerman,et al.  Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. , 2010, Journal of the American College of Cardiology.

[293]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[294]  D. Atsma,et al.  The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening. , 2010, European heart journal.

[295]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[296]  M. Sheppard,et al.  Guidelines for autopsy investigation of sudden cardiac death , 2007, Virchows Archiv.

[297]  S. Szymkiewicz,et al.  Bridging a Temporary High Risk of Sudden Arrhythmic Death. Experience with the Wearable Cardioverter Defibrillator (WCD) , 2010, Pacing and clinical electrophysiology : PACE.

[298]  A. Moss,et al.  Risk of fatal arrhythmic events in long QT syndrome patients after syncope. , 2010, Journal of the American College of Cardiology.

[299]  M Borggrefe,et al.  Long-Term Prognosis of Patients Diagnosed With Brugada Syndrome: Results From the FINGER Brugada Syndrome Registry , 2010, Circulation.

[300]  Akshay S. Desai,et al.  Patient expectations from implantable defibrillators to prevent death in heart failure. , 2010, Journal of cardiac failure.

[301]  D. Pennell,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[302]  Stephan Willems,et al.  Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial , 2010, The Lancet.

[303]  Arthur L. Kellermann,et al.  Predictors of Survival From Out-of-Hospital Cardiac Arrest A Systematic Review and Meta-Analysis , 2013 .

[304]  A. Tajik,et al.  Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.

[305]  G. Hindricks,et al.  Catheter Ablation of Recurrent Scar‐Related Ventricular Tachycardia Using Electroanatomical Mapping and Irrigated Ablation Technology: Results of the Prospective Multicenter Euro‐VT‐Study , 2010, Journal of cardiovascular electrophysiology.

[306]  C. Terkelsen,et al.  Prevalence and significance of accelerated idioventricular rhythm in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. , 2009, The American journal of cardiology.

[307]  A. Habets,et al.  Defibrillator implantation early after myocardial infarction. , 2009, The New England journal of medicine.

[308]  Duanping Liao,et al.  Premature Cardiac Contractions and Risk of Incident Ischemic Stroke , 2009, Journal of the American Heart Association.

[309]  G. Kay,et al.  Electrocardiographic and Electrophysiological Characteristics in Idiopathic Ventricular Arrhythmias Originating From the Papillary Muscles in the Left Ventricle: Relevance for Catheter Ablation , 2009, Circulation. Arrhythmia and electrophysiology.

[310]  P. Roberts,et al.  Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta‐analysis , 2009, European journal of heart failure.

[311]  Louise Adamson,et al.  Does pulmonary valve replacement post repair of tetralogy of Fallot improve right ventricular function? , 2009, Interactive cardiovascular and thoracic surgery.

[312]  G. Breithardt,et al.  QT interval prolongation and risk for cardiac events in genotyped LQTS-index children , 2009, European Journal of Pediatrics.

[313]  G. Marcus,et al.  Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. , 2009, Journal of the American College of Cardiology.

[314]  F. Marchlinski,et al.  Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2009, Circulation.

[315]  W. Williams,et al.  Ventricular arrhythmias and sudden death in adults after a Mustard operation for transposition of the great arteries. , 2009, European heart journal.

[316]  P. Hauptman,et al.  Implantable defibrillators and cardiac resynchronization therapy in heart transplant recipients: results of a national survey. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[317]  G. Bonsel,et al.  Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: The patients' perspective , 2009, American journal of medical genetics. Part A.

[318]  H. Calkins,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. , 2009, Heart rhythm.

[319]  H. Heidbuchel,et al.  Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[320]  M. Ackerman,et al.  Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery. , 2009, Heart rhythm.

[321]  A. Leenhardt,et al.  Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia , 2009, Circulation.

[322]  P. Armstrong,et al.  Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. , 2009, JAMA.

[323]  C. O'connor,et al.  Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials. , 2009, European heart journal.

[324]  C. Autore,et al.  Syncope and Risk of Sudden Death in Hypertrophic Cardiomyopathy , 2009, Circulation.

[325]  A. Wilde,et al.  SCN5A Mutations and the Role of Genetic Background in the Pathophysiology of Brugada Syndrome , 2009, Circulation: Cardiovascular Genetics.

[326]  L. Mestroni,et al.  Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. , 2009, Journal of cardiac failure.

[327]  H. Heidbuchel,et al.  Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization role of drug therapy. , 2009, Journal of the American College of Cardiology.

[328]  S. Hohnloser,et al.  The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. , 2009, Journal of the American College of Cardiology.

[329]  S. Priori,et al.  Yield of Genetic Screening in Inherited Cardiac Channelopathies: How to Prioritize Access to Genetic Testing , 2009, Circulation. Arrhythmia and electrophysiology.

[330]  S. Priori,et al.  High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment “Failures” , 2009, Circulation.

[331]  D. Grobbee,et al.  Long-term prognosis of congenital heart defects: a systematic review. , 2008, International journal of cardiology.

[332]  Warren M. Jackman,et al.  Irrigated Radiofrequency Catheter Ablation Guided by Electroanatomic Mapping for Recurrent Ventricular Tachycardia After Myocardial Infarction: The Multicenter Thermocool Ventricular Tachycardia Ablation Trial , 2008, Circulation.

[333]  S. Solomon,et al.  Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry). , 2008, The American journal of cardiology.

[334]  D. Mark,et al.  Ejection fraction assessment and survival: an analysis of the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). , 2008, American heart journal.

[335]  Jeroen J. Bax,et al.  Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. , 2008, JACC. Cardiovascular imaging.

[336]  S. Viskin,et al.  J-point elevation in survivors of primary ventricular fibrillation and matched control subjects: incidence and clinical significance. , 2008, Journal of the American College of Cardiology.

[337]  L. Tavazzi,et al.  Long-term outcome and risk stratification in dilated cardiolaminopathies. , 2008, Journal of the American College of Cardiology.

[338]  W. Manning,et al.  Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .

[339]  L. Harris,et al.  Sudden Death and Defibrillators in Transposition of the Great Arteries With Intra-atrial Baffles: A Multicenter Study , 2008, Circulation. Arrhythmia and electrophysiology.

[340]  A. Tsiatis,et al.  Quality of life with defibrillator therapy or amiodarone in heart failure. , 2008, The New England journal of medicine.

[341]  Rachael,et al.  Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.

[342]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.

[343]  G. Kay,et al.  Ventricular Tachycardia Originating From the Posterior Papillary Muscle in the Left Ventricle: A Distinct Clinical Syndrome , 2008, Circulation. Arrhythmia and electrophysiology.

[344]  George A. Johnson,et al.  Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. , 2008, Journal of the American College of Cardiology.

[345]  L. Harris,et al.  Implantable Cardioverter-Defibrillators in Tetralogy of Fallot , 2008, Circulation.

[346]  Paul Schweitzer,et al.  Frequent Premature Ventricular Complexes Originating from the Right Ventricular Outflow Tract Are Associated with Left Ventricular Dysfunction , 2008, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[347]  Katja Zeppenfeld,et al.  Catheter Ablation of Ventricular Tachycardia After Repair of Congenital Heart Disease: Electroanatomic Identification of the Critical Right Ventricular Isthmus , 2007, Circulation.

[348]  R. Passman,et al.  Implantable cardioverter defibrillators and quality of life: results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. , 2007, Archives of Internal Medicine.

[349]  A. Moss,et al.  Ventricular arrhythmia storms in postinfarction patients with implantable defibrillators for primary prevention indications: a MADIT-II substudy. , 2007, Heart rhythm.

[350]  P. Tchou,et al.  Surgical Options for Refractory Ventricular Tachycardia , 2007, Journal of cardiac surgery.

[351]  H. Sairanen,et al.  Causes of late deaths after pediatric cardiac surgery: a population-based study. , 2007, Journal of the American College of Cardiology.

[352]  Gerasimos S Filippatos,et al.  Drug-induced long QT syndrome. , 2007, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[353]  B. Vandermeer,et al.  Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction , 2007, Annals of Internal Medicine.

[354]  S. Russell,et al.  Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[355]  M. Link,et al.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. , 2007, JAMA.

[356]  B. Maron,et al.  Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy , 2007, Heart.

[357]  E. Kaufman,et al.  Long QT syndrome and pregnancy. , 2007, Journal of the American College of Cardiology.

[358]  Andrew J. Sauer,et al.  Long QT syndrome in adults. , 2007, Journal of the American College of Cardiology.

[359]  Pamela J Schreiner,et al.  Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk In Communities cohort). , 2006, The American journal of cardiology.

[360]  H. Calkins,et al.  ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology). , 2006, Journal of the American College of Cardiology.

[361]  B. Maron,et al.  Determinants for clinical diagnosis of hypertrophic cardiomyopathy. , 2006, American Journal of Cardiology.

[362]  E P Walsh,et al.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair , 2006, Heart.

[363]  M. Schalij,et al.  Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: a multi-centre study. , 2006, European heart journal.

[364]  R. Lange,et al.  Presence of a Ventricular Septal Defect and the Mustard Operation Are Risk Factors for Late Mortality After the Atrial Switch Operation: Thirty Years of Follow-Up in 417 Patients at a Single Center , 2006, Circulation.

[365]  M. Borggrefe,et al.  Short QT syndrome: clinical findings and diagnostic-therapeutic implications. , 2006, European heart journal.

[366]  Michael J Ackerman,et al.  Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. , 2006, JAMA.

[367]  J. Ornato,et al.  ACC/AHA/ESC PRACTICE GUIDELINES ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death , 2006 .

[368]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[369]  L. Sharples,et al.  A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context. , 2006, Health technology assessment.

[370]  P. Elliott,et al.  Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. , 2006, European heart journal.

[371]  A. Tsiatis,et al.  Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) , 2006, Circulation.

[372]  Alvin I Mushlin,et al.  The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. , 2006, Journal of the American College of Cardiology.

[373]  A. Tajik,et al.  Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[374]  J. A. Gomes,et al.  Risk Stratification of Individuals with the Brugada Electrocardiogram: A Meta‐Analysis , 2006, Journal of cardiovascular electrophysiology.

[375]  C. Snyder,et al.  Verapamil-sensitive ventricular tachycardia in an infant. , 2006, Congenital heart disease.

[376]  D. Tester,et al.  Effect of clinical phenotype on yield of long QT syndrome genetic testing. , 2006, Journal of the American College of Cardiology.

[377]  Y. Pinto,et al.  Primary prevention of sudden death in patients with lamin A/C gene mutations. , 2006, The New England journal of medicine.

[378]  E. Fain,et al.  Comparison of (cid:1) -Blockers, Amiodarone Plus (cid:1) -Blockers, or Sotalol for Prevention of Shocks From Implantable Cardioverter Defibrillators The OPTIC Study: A Randomized Trial , 2005 .

[379]  P. Engelfriet,et al.  The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period. The Euro Heart Survey on adult congenital heart disease. , 2005, European heart journal.

[380]  S. Russell,et al.  Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. , 2005, Heart rhythm.

[381]  Douglas K Owens,et al.  Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.

[382]  W. Shimizu,et al.  Malignant entity of idiopathic ventricular fibrillation and polymorphic ventricular tachycardia initiated by premature extrasystoles originating from the right ventricular outflow tract. , 2005, Journal of the American College of Cardiology.

[383]  A. Moss,et al.  Cost‐Effectiveness of Implanted Defibrillators in Young People with Inherited Cardiac Arrhythmias , 2005, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[384]  A. Russo,et al.  Idiopathic fascicular left ventricular tachycardia: linear ablation lesion strategy for noninducible or nonsustained tachycardia. , 2005, Heart rhythm.

[385]  S. Viskin,et al.  The “Short‐Coupled” Variant of Right Ventricular Outflow Ventricular Tachycardia: A Not‐So‐Benign Form of Benign Ventricular Tachycardia? , 2005, Journal of cardiovascular electrophysiology.

[386]  D. Mehta,et al.  Usefulness of programmed ventricular stimulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. , 2005, The American journal of cardiology.

[387]  S. Solomon,et al.  Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. , 2005, The New England journal of medicine.

[388]  G. Breithardt,et al.  Implantable cardioverter-defibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. , 2005, Heart rhythm.

[389]  R. Califf,et al.  Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-II , 2005, Annals of Internal Medicine.

[390]  A. Nogami,et al.  Idiopathic ventricular arrhythmia arising from the mitral annulus: a distinct subgroup of idiopathic ventricular arrhythmias. , 2005, Journal of the American College of Cardiology.

[391]  Yves L Provost,et al.  Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. , 2005, The American journal of cardiology.

[392]  Akshay S. Desai,et al.  Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. , 2005, JAMA.

[393]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[394]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[395]  John E Billi,et al.  Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European , 2004, Circulation.

[396]  S. Priori,et al.  Association of Long QT Syndrome Loci and Cardiac Events Among Patients Treated With β-Blockers , 2004 .

[397]  George A. Wells,et al.  Advanced Cardiac Life Support in Out-of-Hospital Cardiac Arrest , 2004 .

[398]  B. Hainque,et al.  Low incidence of cardiac events with beta-blocking therapy in children with long QT syndrome. , 2004, European heart journal.

[399]  D. Roden.  Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.

[400]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[401]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[402]  E. Walsh,et al.  Value of Programmed Ventricular Stimulation After Tetralogy of Fallot Repair: A Multicenter Study , 2004, Circulation.

[403]  S. Priori,et al.  Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome , 2004, Circulation.

[404]  W. Stevenson,et al.  Identification and Ablation of Three Types of Ventricular Tachycardia Involving the His‐Purkinje System in Patients with Heart Disease , 2004, Journal of cardiovascular electrophysiology.

[405]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[406]  P. Elliott,et al.  Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. , 2003, Journal of the American College of Cardiology.

[407]  C. Chi,et al.  Verapamil sensitive idiopathic ventricular tachycardia in an infant. , 2003, Japanese heart journal.

[408]  H. Heidbuchel,et al.  High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias. Role of an electrophysiologic study in risk stratification. , 2003, European heart journal.

[409]  F. Morady,et al.  Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. , 2003, Journal of the American College of Cardiology.

[410]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[411]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[412]  A. Moss,et al.  Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients , 2003, Journal of cardiovascular electrophysiology.

[413]  S. Viskin.  Implantable Cardioverter Defibrillator in High‐Risk Long QT Syndrome Patients , 2003, Journal of cardiovascular electrophysiology.

[414]  M. Lauer,et al.  Frequent ventricular ectopy after exercise as a predictor of death. , 2003, The New England journal of medicine.

[415]  R. Krittayaphong,et al.  Effect of atenolol on symptomatic ventricular arrhythmia without structural heart disease: a randomized placebo-controlled study. , 2002, American heart journal.

[416]  M. Josephson,et al.  Relation of Ejection Fraction and Inducible Ventricular Tachycardia to Mode of Death in Patients With Coronary Artery Disease: An Analysis of Patients Enrolled in the Multicenter Unsustained Tachycardia Trial , 2002, Circulation.

[417]  R. Vonthein,et al.  Efficacy of Metoprolol and Sotalol in the Prevention of Recurrences of Sustained Ventricular Tachyarrhythmias in Patients with an Implantable Cardioverter Defibrillator , 2002, Pacing and clinical electrophysiology : PACE.

[418]  C. Haffajee,et al.  Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia. , 2002, The American journal of cardiology.

[419]  G. Sanders,et al.  Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. , 2002, American heart journal.

[420]  M. Shoda,et al.  Mapping and Ablation of Idiopathic Ventricular Fibrillation , 2002, Circulation.

[421]  B. Maron,et al.  Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. , 2002, Journal of the American College of Cardiology.

[422]  R. Califf,et al.  Sustained Ventricular Arrhythmias Among Patients With Acute Coronary Syndromes With No ST-Segment Elevation: Incidence, Predictors, and Outcomes , 2002, Circulation.

[423]  Carlo Napolitano,et al.  Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia , 2002, Circulation.

[424]  A. Tajik,et al.  Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. , 2002, Journal of the American College of Cardiology.

[425]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[426]  Judy Powell,et al.  Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry. , 2002, American heart journal.

[427]  B. Strasberg,et al.  Usefulness of implantable cardioverter-defibrillators in refractory variant angina pectoris complicated by ventricular fibrillation in patients with angiographically normal coronary arteries. , 2002, The American journal of cardiology.

[428]  K. McDonald,et al.  Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries , 2002 .

[429]  G. Larsen,et al.  Cost-Effectiveness of the Implantable Cardioverter-Defibrillator Versus Antiarrhythmic Drugs in Survivors of Serious Ventricular Tachyarrhythmias: Results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Economic Analysis Substudy , 2002, Circulation.

[430]  K. Kuck,et al.  Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT) , 2002, Circulation.

[431]  K. Kuck,et al.  Primary Prevention of Sudden Cardiac Death in Idiopathic Dilated Cardiomyopathy: The Cardiomyopathy Trial (CAT) , 2002, Circulation.

[432]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[433]  P. Dorian,et al.  Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. , 2002, The New England journal of medicine.

[434]  Michel Haïssaguerre,et al.  Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation , 2002, The Lancet.

[435]  M. Isobe,et al.  National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[436]  C. Jagger,et al.  A randomised trial to investigate the efficacy of magnesium sulphate for refractory ventricular fibrillation , 2002, Emergency medicine journal : EMJ.

[437]  J J Bailey,et al.  Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction. , 2001, Journal of the American College of Cardiology.

[438]  M. Isobe,et al.  Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. , 2001, The American journal of cardiology.

[439]  W. Shen,et al.  Role of Programmed Ventricular Stimulation and Implantable Cardioverter Defibrillators in Patients with Idiopathic Dilated Cardiomyopathy and Syncope , 2001, Pacing and clinical electrophysiology : PACE.

[440]  G. Laufer,et al.  Survival Benefit of the Implantable Cardioverter-Defibrillator in Patients on the Waiting List for Cardiac Transplantation , 2001, Circulation.

[441]  G. Schmidt,et al.  Value of programmed ventricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. , 2001, Journal of the American College of Cardiology.

[442]  Geoffrey I. Webb,et al.  Impact of Pulmonary Valve Replacement on Arrhythmia Propensity Late After Repair of Tetralogy of Fallot , 2001, Circulation.

[443]  H. Dargie,et al.  Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.

[444]  A. Iwasa,et al.  Effects of verapamil and lidocaine on two components of the re-entry circuit of verapamil-senstitive idiopathic left ventricular tachycardia. , 2001, Journal of the American College of Cardiology.

[445]  M Gent,et al.  Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: Results From the Canadian Implantable Defibrillator Study (CIDS) , 2001, Circulation.

[446]  R. Myerburg,et al.  Sudden Cardiac Death: Exploring the Limits of Our Knowledge , 2001, Journal of cardiovascular electrophysiology.

[447]  P. Elliott,et al.  Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.

[448]  J. Brugada,et al.  Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: effects on the electrophysiologic substrate and outcome. , 2001, Journal of the American College of Cardiology.

[449]  R. Gow.  Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2001, Circulation.

[450]  A. Hallstrom,et al.  “Stable” Ventricular Tachycardia Is Not a Benign Rhythm: Insights From the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry , 2001, Circulation.

[451]  P. Elliott,et al.  Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.

[452]  S. Connolly,et al.  Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. , 2000, European heart journal.

[453]  S. Siu,et al.  Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.

[454]  X. Jouven,et al.  Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations , 2000 .

[455]  Y. Iesaka,et al.  Demonstration of diastolic and presystolic Purkinje potentials as critical potentials in a macroreentry circuit of verapamil-sensitive idiopathic left ventricular tachycardia. , 2000, Journal of the American College of Cardiology.

[456]  R. Cappato,et al.  Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). , 2000, Circulation.

[457]  K. Nademanee,et al.  Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. , 2000, Circulation.

[458]  K. Lee,et al.  Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. , 2000, The New England journal of medicine.

[459]  B. Maron,et al.  Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[460]  G. Fonarow,et al.  Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. , 2000, The American journal of cardiology.

[461]  M Gent,et al.  Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone. , 2000, Circulation.

[462]  S. Priori,et al.  Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. , 2000, Circulation.

[463]  M. Link,et al.  Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.

[464]  M. Elizari,et al.  Morbidity and mortality following early administration of amiodarone in acute myocardial infarction , 2000 .

[465]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[466]  P. Carli,et al.  A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospital. European Epinephrine Study Group. , 1999, The New England journal of medicine.

[467]  P. Cullinan,et al.  Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. , 1999, Circulation.

[468]  A. Camm,et al.  Examining the psychosocial impact of implantable cardioverter defibrillators: A literature review , 1999, Clinical cardiology.

[469]  S. Hohnloser,et al.  Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. , 1999, The New England journal of medicine.

[470]  F. Morady,et al.  Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. , 1999, Journal of the American College of Cardiology.

[471]  B. Maron,et al.  Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .

[472]  P. Elliott,et al.  Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy. , 1999, Journal of the American College of Cardiology.

[473]  R. Sciacca,et al.  New-onset sustained ventricular tachycardia after cardiac surgery. , 1999, Circulation.

[474]  R Yee,et al.  Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. , 1999, Circulation.

[475]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[476]  P. Carli,et al.  A Comparison of Repeated High Doses and Repeated Standard Doses of Epinephrine for Cardiac Arrest Outside the Hospital , 1998 .

[477]  T. Imaizumi,et al.  Predictors of sudden cardiac death in hypertrophic cardiomyopathy. , 1998, The American journal of cardiology.

[478]  José A. Sobrino,et al.  Mechanisms of sustained ventricular tachycardia in myotonic dystrophy: implications for catheter ablation. , 1998, Circulation.

[479]  M. Silka,et al.  A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. , 1998, Journal of the American College of Cardiology.

[480]  A I Mushlin,et al.  The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial. , 1998, Circulation.

[481]  F. Suliman,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. , 1998, The New England journal of medicine.

[482]  J. Thomas,et al.  Prognostic significance of exercise-induced left bundle-branch block. , 1998, JAMA.

[483]  Huabin Sun,et al.  The Value of Electrophysiology Study and Prophylactic Implantation of Cardioverter Defibrillator in Patients with Hypertrophic Cardiomyopathy , 1998, Pacing and clinical electrophysiology : PACE.

[484]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[485]  Bigger Jt,et al.  Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery , 1997 .

[486]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[487]  A. Natale,et al.  Implantable cardioverter-defibrillators and pregnancy: a safe combination? , 1997, Circulation.

[488]  W. Mckenna,et al.  Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. , 1997, Circulation.

[489]  R. Califf,et al.  Randomised trial of magnesium in in-hospital cardiac arrest , 1997, The Lancet.

[490]  Geoffrey I. Webb,et al.  Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot. , 1997, Journal of the American College of Cardiology.

[491]  D. Roden,et al.  Normalization of acquired QT prolongation in humans by intravenous potassium. , 1997, Circulation.

[492]  G. Berry,et al.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. , 1997, The New England journal of medicine.

[493]  J. Dhainaut,et al.  Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. , 1997, The New England journal of medicine.

[494]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[495]  I. V. Van Gelder,et al.  Sudden Cardiac Death in Adult Congenital Heart Disease , 1996, Circulation.

[496]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[497]  R. Mulleneers,et al.  Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. , 1996, The American journal of cardiology.

[498]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[499]  D. Roden,et al.  Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence. , 1996, Circulation.

[500]  B. Maron,et al.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. , 1995, Journal of the American College of Cardiology.

[501]  P. Tchou,et al.  Long‐Term Clinical Outcome of Right Bundle Branch Radiofrequency Catheter Ablation for Treatment of Bundle Branch Reentrant Ventricular Tachycardia , 1995, Pacing and clinical electrophysiology : PACE.

[502]  W. Williams,et al.  Hypertrophic cardiomyopathy. Clinical spectrum and treatment. , 1995, Circulation.

[503]  M. Gatzoulis,et al.  Mechanoelectrical interaction in tetralogy of Fallot. QRS prolongation relates to right ventricular size and predicts malignant ventricular arrhythmias and sudden death. , 1995, Circulation.

[504]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[505]  J. Uther,et al.  Double-blind trial of lignocaine versus sotalol for acute termination of spontaneous sustained ventricular tachycardia , 1994, The Lancet.

[506]  A. Camm,et al.  Verapamil for the suppression of idiopathic ventricular tachycardia of left bundle branch block-like morphology. , 1993, American heart journal.

[507]  C. Furberg,et al.  Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. , 1993, JAMA.

[508]  S. Deshpande,et al.  Bundle Branch Reentrant Ventricular Tachycardia: , 1993, Journal of cardiovascular electrophysiology.

[509]  C. Barton,et al.  A randomized clinical trial of high-dose epinephrine and norepinephrine vs standard-dose epinephrine in prehospital cardiac arrest. , 1992, JAMA.

[510]  A. Camm,et al.  Comparison of Verapamil and Diltiazem in the Suppression of Idiopathic Ventricular Tachycardia , 1992, Pacing and clinical electrophysiology : PACE.

[511]  W. Weaver,et al.  Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. , 1992, Journal of the American College of Cardiology.

[512]  P. Schwartz,et al.  Prevention of Sudden Cardiac Death After a First Myocardial Infarction by Pharmacologic or Surgical Antiadrenergic Interventions , 1992 .

[513]  J. Goin,et al.  Quinidine‐Related Mortality in the Short‐to‐Medium‐Term Treatment of Ventricular Arrhythmias: A Meta‐Analysis , 1991, Circulation.

[514]  J. Bourke,et al.  Routine programmed electrical stimulation in survivors of acute myocardial infarction for prediction of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. , 1991, Journal of the American College of Cardiology.

[515]  P. Gillette,et al.  Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. , 1991, Journal of the American College of Cardiology.

[516]  F. Tristani,et al.  A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.

[517]  Josep Brugada,et al.  A New Approach to the Differential Diagnosis of a Regular Tachycardia With a Wide QRS Complex , 1991, Circulation.

[518]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[519]  G. Divine,et al.  Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. , 1990, The American journal of cardiology.

[520]  E. Antman,et al.  Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. , 1990, Circulation.

[521]  A. Garson,et al.  Ventricular arrhythmias in postoperative tetralogy of Fallot. , 1990, The American journal of cardiology.

[522]  A. Maggioni,et al.  One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. , 1989, The American journal of cardiology.

[523]  D. Echt,et al.  Evaluation of antiarrhythmic drugs on defibrillation energy requirements in dogs. Sodium channel block and action potential prolongation. , 1989, Circulation.

[524]  C. Schuger,et al.  Wide QRS tachycardia in the conscious adult. Ventricular tachycardia is the most frequent cause. , 1989, JAMA.

[525]  W. Kapoor,et al.  Long-term prognosis of patients undergoing electrophysiologic studies for syncope of unknown origin. , 1988, The American journal of cardiology.

[526]  K Shimomura,et al.  Idiopathic sustained left ventricular tachycardia: clinical and electrophysiologic characteristics. , 1988, Circulation.

[527]  K. Kuck,et al.  Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope. , 1988, European heart journal.

[528]  A. Keren,et al.  Treatment of torsade de pointes with magnesium sulfate. , 1988, Circulation.

[529]  B. Deal,et al.  Electrophysiologic drug testing in symptomatic ventricular arrhythmias after repair of tetralogy of Fallot. , 1987, The American journal of cardiology.

[530]  M. Josephson,et al.  Hazards of intravenous verapamil for sustained ventricular tachycardia. , 1987, The American journal of cardiology.

[531]  C. Oakley,et al.  Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. , 1985, British heart journal.

[532]  L. Horowitz,et al.  Use of intravenous verapamil for ventricular tachycardia. , 1984, The American journal of cardiology.

[533]  D. Packer,et al.  Ventricular tachycardia induced by atrial stimulation in patients without symptomatic cardiac disease. , 1983, The American journal of cardiology.

[534]  A. Camm,et al.  Effect of the Antiarrhythmic Agent Flecainide Acetate on Acute and Chronic Pacing Thresholds , 1983, Pacing and clinical electrophysiology : PACE.

[535]  S. Laniado,et al.  Response of recurrent sustained ventricular tachycardia to verapamil. , 1981, British heart journal.

[536]  A. Keren,et al.  Etiology, Warning Signs and Therapy of Torsade de Pointes: A Study of 10 Patients , 1981, Circulation.

[537]  J. Goldberg,et al.  Ventricular Premature Complexes and Sudden Death After Myocardial Infarction , 1981, Circulation.

[538]  N. El-Sherif,et al.  Canine Ventricular Arrhythmias in the Late Myocardial Infarction Period , 1981, Circulation research.

[539]  J. Goldberg,et al.  Ventricular premature beats and mortality after myocardial infarction. , 1977, The New England journal of medicine.

[540]  M. Brodsky,et al.  Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 male medical students without apparent heart disease. , 1977, The American journal of cardiology.

[541]  T. Nealon.  The American Association for Thoracic Surgery , 1972 .

[542]  R. Hiss,et al.  Electrocardiographic Findings in 122,043 Individuals , 1962, Circulation.

[543]  D. Driscoll,et al.  Sudden cardiac death and late arrhythmias after the Fontan operation , 2017, Congenital heart disease.

[544]  S. Duval,et al.  Impact of Implantable Cardioverter-Defibrillators on Waitlist Mortality Among Patients Awaiting Heart Transplantation: An UNOS/OPTN Analysis. , 2017, JACC. Clinical electrophysiology.

[545]  William J. Bryant,et al.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2017, Journal of the American College of Cardiology.

[546]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.

[547]  H. Calkins,et al.  Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. , 2016, Heart rhythm.

[548]  J. Cigarroa,et al.  Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.

[549]  H. Calkins,et al.  2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. , 2016, Journal of the American College of Cardiology.

[550]  B. McNally,et al.  Arrest and Cardiopulmonary Resuscitation Outcome Reports : pdate of the Utstein Resuscitation Registry Templates for ut-of-Hospital Cardiac Arrest Statement for Healthcare Professionals From a Task Force of the nternational Liaison Committee on Resuscitation , 2015 .

[551]  E. Topol,et al.  Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. , 2014, The American journal of medicine.

[552]  M. Brennan,et al.  Amiodarone-induced thyrotoxicosis in adults with congenital heart disease--clinical presentation and response to therapy. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[553]  F. Fynn-Thompson,et al.  Left thoracoscopic sympathectomy for cardiac denervation in patients with life-threatening ventricular arrhythmias. , 2014, The Journal of thoracic and cardiovascular surgery.

[554]  Yingying Tang,et al.  Molecular diagnostics of cardiovascular diseases in sudden unexplained death. , 2014, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[555]  Andrew D. Krahn,et al.  Cardiac Arrest and Sudden Cardiac Death , 2014 .

[556]  L. Shaw,et al.  ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[557]  Jennifer G. Robinson,et al.  Reply: 2013 ACC/AHA guideline on the assessment of cardiovascular risk. , 2014, Journal of the American College of Cardiology.

[558]  Hugh Calkins,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2014, Journal of the American College of Cardiology.

[559]  Jeffrey L. Anderson,et al.  The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[560]  L. Eckardt,et al.  Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study. , 2013, Heart rhythm.

[561]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[562]  Deepak L. Bhatt,et al.  2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[563]  M. Nishizaki,et al.  Clinical implications of an implantable cardioverter-defibrillator in patients with vasospastic angina and lethal ventricular arrhythmia. , 2012, Journal of the American College of Cardiology.

[564]  K. Mahaffey,et al.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation , 2012 .

[565]  F. Cuoco.  Incidence and Predictors of Implantable Cardioverter-Defibrillator Therapy in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Undergoing Implantable Cardioverter-Defibrillator Implantation for Primary Prevention , 2012 .

[566]  S. Greenfield,et al.  COMMITTEE ON STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES , 2011 .

[567]  S. Greenfield,et al.  Clinical practice guidelines we can trust , 2011 .

[568]  髙木 祐介.  Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest : multicenter registry study of the Japanese coronary spasm association , 2011 .

[569]  P. Libby,et al.  Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features , 2011 .

[570]  Laura A. Levit,et al.  Finding what works in health care : standards for systematic reviews , 2011 .

[571]  G. Levine,et al.  ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions , 2011 .

[572]  R. Friedman,et al.  Use of a Cardioselective Beta-Blocker for Pediatric Patients With Prolonged QT Syndrome , 2010, Pediatric Cardiology.

[573]  A. Moss,et al.  Examination of the Effect of Implantable Cardioverter-Defibrillators on Health-Related Quality of Life , 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[574]  Claudia Stöllberger,et al.  Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2009, Heart rhythm.

[575]  S. Priori,et al.  High Efficacy of (cid:1) -Blockers in Long-QT Syndrome Type 1 Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of (cid:1) -Blocker Treatment “Failures” , 2009 .

[576]  G. Kay,et al.  Advances in Arrhythmia and Electrophysiology The Left Ventricular Ostium An Anatomic Concept Relevant to Idiopathic Ventricular Arrhythmias , 2008 .

[577]  D. Zipes,et al.  Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. , 2008, The New England journal of medicine.

[578]  Gd Rotterdam.  Outcome of implantable cardioverter defibrillators in adults with congenital heart disease: A multi-centre study , 2007 .

[579]  P. Insulander,et al.  Surgery for ventricular tachycardia in patients undergoing left ventricular reconstruction by the Dor procedure. , 2006, The Annals of thoracic surgery.

[580]  H. Crijns,et al.  Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? , 2004, Journal of Molecular Medicine.

[581]  Giuseppe Curigliano,et al.  Drug-induced prolongation of the QT interval. , 2004, The New England journal of medicine.

[582]  B. Gersh,et al.  Functional and prognostic significance of exercise-induced ventricular arrhythmias in patients with suspected coronary artery disease. , 2002, The American journal of cardiology.

[583]  D. Levy,et al.  Incidence and prognosis of syncope. , 2002, The New England journal of medicine.

[584]  M. Ichael,et al.  AMIODARONE FOR RESUSCITATION AFTER OUT-OF-HOSPITAL CARDIAC ARREST DUE TO VENTRICULAR FIBRILLATION , 1999 .

[585]  P. Touboul,et al.  Arrhythmic cardiac arrest due to isolated coronary artery spasm: long-term outcome of seven resuscitated patients. , 1998, Journal of the American College of Cardiology.

[586]  L. Ekström,et al.  Lidocaine in out-of-hospital ventricular fibrillation. Does it improve survival? , 1997, Resuscitation.

[587]  R. Winkle,et al.  Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group. , 1996, Journal of the American College of Cardiology.

[588]  P. Coumel,et al.  Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. , 1994, Circulation.

[589]  W. Stevenson,et al.  Syncope in advanced heart failure: high risk of sudden death regardless of origin of syncope. , 1993, Journal of the American College of Cardiology.

[590]  A. Castellanos,et al.  Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. , 1992, The New England journal of medicine.

[591]  J. Kaufmann.  Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm. , 1992, The New England journal of medicine.

[592]  Robert Lemery,et al.  Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. , 1992, The New England journal of medicine.

[593]  J. Mason,et al.  Electrophysiologic testing in patients with the long QT syndrome. , 1985, Circulation.

[594]  H. Wellens,et al.  The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. , 1978, The American journal of medicine.

[595]  S. Narayan,et al.  Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. , 2009, Journal of the American College of Cardiology.